{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:05:00Z","timestamp":1789009500379,"version":"build-2803163510"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejmech.2025.117331","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:48:34Z","timestamp":1738208914000},"page":"117331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6537-5979","authenticated-orcid":false,"given":"Dina H.","family":"Dawood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal M.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117331_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1517\/13543776.2012.701620","article-title":"Acetylcholinesterase inhibitors: a patent review (2008 - present)","volume":"22","author":"Pohanka","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117331_bib2","first-page":"2340","article-title":"The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase","volume":"118","author":"Harel","year":"1996","journal-title":"J. Appl. Comput. Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117331_bib5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V81.3.815.815","article-title":"Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype","volume":"8","author":"Rao","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.117331_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tins.2006.02.005","article-title":"Virtues and woes of AChE alternative splicing in stress-related neuropathologies","volume":"29","author":"Meshorer","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2025.117331_bib7","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1371\/journal.pone.0003108","article-title":"N-acetylcholinesterase induced apoptosis in Alzheimer's disease","volume":"3","author":"Toiber","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117331_bib8","first-page":"40","article-title":"Acetylcholinesterase involvement in apoptosis","volume":"5","author":"hang","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117331_bib9","first-page":"1013","article-title":"Overexpression of acetylcholinesterase inhibited cell proliferation and promoted apoptosis in NRK cells","volume":"25","author":"Jin","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117331_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/13543776.2017.1272571","article-title":"Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)","volume":"27","author":"F McHardy","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117331_bib11","series-title":"Encyclopedia of Neuroscience","author":"Taylor","year":"2009"},{"key":"10.1016\/j.ejmech.2025.117331_bib12","series-title":"Handbook of Toxicology of Chemical Warfare Agents","article-title":"50-Toxicokinetics of chemical warfare agents: nerve agents and vesicants","author":"John","year":"2009"},{"key":"10.1016\/j.ejmech.2025.117331_bib13","first-page":"1","article-title":"Twenty years research in cholinesterase biosensors: from basic research to practical applications, Biomol","volume":"23","author":"Andreescu","year":"2006","journal-title":"Eng."},{"key":"10.1016\/j.ejmech.2025.117331_bib14","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.3390\/s120607893","article-title":"Acetylcholinesterase immobilized on magnetic beads for pesticides detection: application to olive oil analysis","volume":"12","author":"Ben Oujji","year":"2012","journal-title":"Sensors"},{"key":"10.1016\/j.ejmech.2025.117331_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2019.08.005","article-title":"Alzheimer's disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview","volume":"73","author":"Matej","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejmech.2025.117331_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer's disease facts and figures","volume":"11","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ejmech.2025.117331_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/brainsci10080479","article-title":"The neuropathological diagnosis of Alzheimer's disease-the challenges of pathological mimics and concomitant pathology","volume":"10","author":"King","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nrl.2016.02.016","article-title":"Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis","volume":"32","author":"Niu","year":"2017","journal-title":"Neurologia"},{"key":"10.1016\/j.ejmech.2025.117331_bib19","first-page":"960","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years, J. Neuropathol","volume":"70","author":"Braak","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.117331_bib20","series-title":"Towards a Dementia Plan: A WHO Guide","author":"World Health","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117331_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer\u2019s Dement, J. Alzheimer\u2019s Assoc."},{"key":"10.1016\/j.ejmech.2025.117331_bib22","first-page":"1689","article-title":"Efficacy of acetylcholinesterase inhibitors on cognitive function in Alzheimer's disease","volume":"9","author":"P\u00e9rez-G\u00f3mez Moreta","year":"2021","journal-title":"Review of Reviews, Biomedicines"},{"key":"10.1016\/j.ejmech.2025.117331_bib23","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2025.117331_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117331_bib25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.117331_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2008.05.050","article-title":"Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice","volume":"440","author":"Gu","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2025.117331_bib27","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.31434\/rms.v5i4.442","article-title":"Influencia de la enfermedad de Alzheimer en los sistemas de neurotransmisi\u00f3n sin\u00e1ptica","volume":"5","author":"\u00c1lvarez Castillo","year":"2020","journal-title":"Rev. Med. Sinerg."},{"key":"10.1016\/j.ejmech.2025.117331_bib28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2025.117331_bib29","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0047-6374(01)00310-4","article-title":"Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?","volume":"122","author":"Amenta","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2025.117331_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117331_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainresbull.2019.01.004","article-title":"Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease","volume":"146","author":"Madav","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2025.117331_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"25","key":"10.1016\/j.ejmech.2025.117331_bib33","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117331_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.clineuro.2010.06.018","article-title":"Benefits from sustained\u2010release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open\u2010label trial","volume":"112","author":"Sieb","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117331_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/17425255.2013.736489","article-title":"Toxicological considerations of acetylcholinesterase reactivators","volume":"9","author":"Voicu","year":"2013","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117331_bib36","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Walczak-Nowicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117331_bib37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/138620712800563891","article-title":"Classification of acetylcholinesterase inhibitors and decoys by a support vector machine","volume":"15","author":"Wang","year":"2012","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117331_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117331_bib39","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/toxics11100866","article-title":"Mechanisms of organophosphate toxicity and the role of acetylcholinesterase inhibition","volume":"11","author":"Aroniadou-Anderjaska","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.ejmech.2025.117331_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1254\/jphs.11R01CR","article-title":"Pharmacological aspects of the acetylcholinesterase inhibitor galantamine","volume":"116","author":"Ago","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2025.117331_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/cc000002f","article-title":"Recent advances in the preparation of heterocycles on solid support: a review of the literature","volume":"2","author":"Franzen","year":"2000","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib43","first-page":"3118","article-title":"Ueber verbindungen des thiazols (pyridins der thiophenreihe)","volume":"20","author":"Hantzsch","year":"1887","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib44","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.3390\/molecules26113166","article-title":"Thiazole ring-a biologically active scaffold","volume":"26","author":"Petrou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117331_bib45","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/molecules27133994","article-title":"Thiazole: a versatile standalone moiety contributing to the development of various drugs and biologically active agents","volume":"27","author":"Arshad","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117331_bib46","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/jm00362a014","article-title":"N-(4-Substituted-thiazolyl) oxamic acid derivatives, new series of potent, orally active antiallergy agents","volume":"26","author":"Hargrave","year":"1983","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib47","first-page":"226","article-title":"Anti- inflammatory, analgesic and anti-ulcerogenic activities of novel bis-thiadiazoles, bis-thiazoles and bis-formazanes, Med","volume":"13","author":"Muhammad","year":"2017","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.117331_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/1573406412666160201121310","article-title":"Synthesis, antibacterial activity, interaction with nucleobase and molecular docking studies of 4-formylbenzoic acid based thiazoles","volume":"12","author":"Z Laczkowski","year":"2016","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib49","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/jm00092a006","article-title":"Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors","volume":"35","author":"Patt","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00044-008-9089-0","article-title":"Design, synthesis, andantimalarial evaluation of thiazole-derived amino acids","volume":"17","author":"Karade","year":"2008","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117331_bib51","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/(SICI)1521-4184(199910)332:10<343::AID-ARDP343>3.0.CO;2-0","article-title":"Synthesis and hypnotic activity of new 4-thiazolidinone and 2-thioxo-4,5- imidazolidinedione derivatives","volume":"332","author":"Ergen\u00e7","year":"1999","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117331_bib52","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.bmcl.2007.05.036","article-title":"Design and synthesis of 1, 2- dithiolane derivatives and evaluation of their neuroprotective activity","volume":"17","author":"Koufaki","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117331_bib53","first-page":"32","article-title":"Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives","volume":"1","author":"Jubie","year":"2009","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejmech.2015.04.015","article-title":"Recent applications of 1, 3-thiazole core structure in the identification of new lead compounds and drug discovery","volume":"97","author":"Ayati","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib55","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4155\/fmc-2018-0196","article-title":"Recent advances of thiazole hybrids in biological applications","volume":"11","author":"G\u00fcm\u00fc\u015f","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131063","article-title":"Alkyl 2-(2-(arylidene)alkylhydrazinyl)thiazole-4-carboxylates: synthesis, acetyl cholinesterase inhibition and docking studies","volume":"1245","author":"Haroon","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bioorg.2015.08.002","article-title":"Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease","volume":"62","author":"Rahim","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib58","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3390\/molecules25184312","article-title":"Design, synthesis, and structure\u2013activity relationships of thiazole analogs as anticholinesterase agents for Alzheimer's disease","volume":"25","author":"Saglik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117331_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137585","article-title":"In vitro and in silico correlation of bis-thiazole based Schiff base hybrids analogues: a computational approach develop to promising acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"1303","author":"Jehangir","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bioorg.2018.12.002","article-title":"One-pot four-component synthesis of thiazolidin-2-imines using CuI\/Zn II dual catalysis: a new class of acetylcholinesterase inhibitors","volume":"84","author":"Shehzadi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14756366.2017.1389920","article-title":"Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site","volume":"33","author":"Tripathi","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib62","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00044-019-02405-6","article-title":"Synthesis, in vitro assays, molecular docking, theoretical ADMET prediction, and evaluation of 4-methoxy-phenylthiazole-2-amine derivatives as acetylcholinesterase inhibitors","volume":"28","author":"Zhang","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117331_bib63","article-title":"Design, synthesis and evaluation of new 4-arylthiazole-2-amine derivatives as acetylcholinesterase inhibitors","volume":"30","author":"Xu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117331_bib64","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14233\/ajchem.2024.31241","article-title":"Synthesis and evaluation of aminothiazole hybrids as potential acetylcholinesterase inhibitors","volume":"36","author":"Artisoni","year":"2024","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300054","article-title":"Synthesis and evaluation of multitarget new 2\u2010aminothiazole derivatives as potential anti\u2010Alzheimer's agents","volume":"356","author":"Bardakkaya","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117331_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138760","article-title":"Evaluation of 3,4-diethoxy substituted thioureas and their thiazole derivatives as potent anti-Alzheimer\u2019s agents: synthesis, DFT, biological activity and molecular modeling investigations","volume":"1314","author":"Mahmood","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib67","first-page":"258","article-title":"Biological evaluation of thiazole derivatives bearing dithiocarbmate moiety as potential cholinesterase inhibitors","volume":"7","author":"Abu Mohsen","year":"2015","journal-title":"Int. J.Pharm.Pharm.Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib68","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bmcl.2016.01.001","article-title":"Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's","volume":"26","author":"Sun","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117331_bib69","article-title":"Abdul Wadood, Synthesis, in vitro acetylcholinesterase, butyrylcholinesterase activities and in silico molecular docking study of thiazole-thiourea hybrid derivatives","volume":"45","author":"Ullah","year":"2023","journal-title":"Chem. Data Coll."},{"key":"10.1016\/j.ejmech.2025.117331_bib70","article-title":"Synthesis, acetylcholinesterase and butyrylcholinesterase inhibitory potential and molecular docking study of thiazole bearing thiourea analogues","volume":"44","author":"Ullah","year":"2023","journal-title":"Chem. Data Coll."},{"key":"10.1016\/j.ejmech.2025.117331_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100294","article-title":"Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds","volume":"354","author":"Sever","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117331_bib72","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","article-title":"Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors","volume":"163","author":"Sever","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.117331_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200294","article-title":"Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4\u2010oxadiazole Derivatives","volume":"355","author":"Durmaz","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117331_bib74","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/acs.jmedchem.6b00426","article-title":"Benzylpiperidine-linked diarylthiazoles as potential anti-Alzheimer\u2019s agents-synthesis and biological evaluation","volume":"59","author":"Shidore","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib75","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3109\/14756366.2012.709242","article-title":"Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors","volume":"28","author":"Yurtta\u015f","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib76","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ddr.21481","article-title":"Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors","volume":"79","author":"Sahin","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.117331_bib77","first-page":"1","article-title":"Novel thiazole\u2010piperazine derivatives as potential cholinesterase inhibitors","author":"Demirayak","year":"2019","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib78","first-page":"608","article-title":"Multipotent cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, biological analysis and molecular docking study of benzimidazole-based thiazole derivatives","volume":"27","author":"Hussain","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117331_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137417","article-title":"Novel bis-thiazole-thiazolidinone hybrid derivatives: synthesis, structural properties and anticholinesterase bioactive potential as drug competitor based on docking studies","volume":"1303","author":"Khan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300201","article-title":"Synthesis and molecular docking simulation of new benzimidazole\u2013thiazole hybrids as cholinesterase inhibitors","volume":"357","author":"Dawood","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117331_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103895","article-title":"Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors","volume":"100","author":"Mroueh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib82","doi-asserted-by":"crossref","DOI":"10.1039\/D2RA04183A","article-title":"Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies","volume":"12","author":"Javed","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117331_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101603","article-title":"Design, Synthesis, in vitro biological evaluation and in silico molecular docking study of chloro substituted Benzimidazole-Thiazole hybrid derivatives as potential Anti-Alzheimer\u2019s agents","volume":"8","author":"Kaleem","year":"2024","journal-title":"Results in Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2022.100253","article-title":"Benzoxazole based thiazole hybrid analogs: synthesis, in vitro cholinesterase inhibition, and molecular docking studies","volume":"25","author":"Hussain","year":"2023","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117331_bib85","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1747519820948358","article-title":"Synthesis and anti-acetylcholinesterase activities of novel glycosyl coumarylthiazole derivatives","volume":"45","author":"Wang","year":"2021","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117331_bib86","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1747-0285.2012.01435.x","article-title":"Synthesis and biological evaluation of 3-thiazolocoumarinyl schiff-base derivatives as cholinesterase inhibitors","volume":"80","author":"Raza","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117331_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14756366.2016.1250753","article-title":"Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitor","volume":"32","author":"Sonmez","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104792","article-title":"Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease","volume":"110","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111651","article-title":"Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives","volume":"182","author":"Mahmoud","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00061","article-title":"Combined in vitro and in silico studies for the anticholinesterase activity and pharmacokinetics of coumarinyl thiazoles and oxadiazoles","volume":"6","author":"Ibrar","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib91","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bioorg.2015.02.002","article-title":"Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives","volume":"59","author":"Kurt","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137365","article-title":"New naphthoquinone thiazole hybrids as carbonic anhydrase and cholinesterase inhibitors: synthesis, crystal structure, molecular docking, and acid dissociation constant","volume":"1301","author":"Efeoglu","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib93","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14756366.2019.1680659","article-title":"Synthesis of thiazolidin-4-ones and thiazinan-4-ones from 1-(2-aminoethyl) pyrrolidine as acetylcholinesterase inhibitors","volume":"35","author":"das Neves","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132384","article-title":"Synthesis, single crystal, in-silico and in-vitro assessment of the thiazolidinones","volume":"1255","author":"Aisha","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib95","doi-asserted-by":"crossref","first-page":"19202","DOI":"10.1021\/acsomega.1c02549","article-title":"Synthesis and biological evaluation of thiazole-based derivatives as potential acetylcholinesterase inhibitors","volume":"6","author":"Hemaida","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.117331_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137417","article-title":"Novel bis-thiazole-thiazolidinone hybrid derivatives: synthesis, structural properties and anticholinesterase bioactive potential as drug competitor based on docking studies","volume":"1303","author":"Khan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200323","article-title":"Synthesis and molecular docking of new bis-thiazolidinone-based chalcone analogs as effective inhibitors of acetylcholinesterase and butyrylcholinesterase","volume":"19","author":"Hussain","year":"2022","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.ejmech.2025.117331_bib98","first-page":"2800","article-title":"Hybrids of thiazolidin-4-ones and 1,3,4-thiadiazole: synthesis and biological screening of A potential new class of acetylcholinesterae inhibitors","volume":"12","author":"Aggarwal","year":"2022","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib99","article-title":"Synthesis, characterization, biological evaluation, and molecular docking studies of some piperonyl\u2010based 4\u2010thiazolidinone derivatives","volume":"353","author":"Bilgicli","year":"2020","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117331_bib100","first-page":"1759","article-title":"Glycosyl thiourea: synthesis, cyclization, reaction, molecular docking, and evaluation as potential acetylcholinesterase inhibitors, Egypt","volume":"66","author":"Ellithy","year":"2023","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib101","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/14756366.2011.653355","article-title":"Synthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitors","volume":"28","author":"Turan-Zitouni","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113124","article-title":"Design, synthesis and biological evaluation of new benzoxazolone\/benzothiazolone derivatives as multi-target agents against Alzheimer's disease","volume":"212","author":"Erdogan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib103","article-title":"In silico and in vitro studies of benzothiazole-isothioureas derivatives as a multitarget compound for Alzheimer's disease","volume":"23","author":"Hern\u00e1ndez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137118","article-title":"Novel benzothiazole sulfonamides as potent \u03b1-glucosidase and cholinesterase inhibitors: design, synthesis, structural properties, biological evaluation and docking studies","volume":"1299","author":"Khair-ul-Bariyah","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib105","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2175821","article-title":"Novel benzothiazole derivatives as multitargeted- directed ligands for the treatment of Alzheimer's disease","volume":"38","author":"Hafez","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib106","first-page":"176","article-title":"Synthesis and evaluation of anti-acetylcholinesterase activity of some benzothiazole based new piperazine-dithiocarbamate derivatives","volume":"65","author":"Mohsen","year":"2015","journal-title":"Drug Res."},{"key":"10.1016\/j.ejmech.2025.117331_bib107","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1016\/j.bmcl.2016.10.041","article-title":"Design, synthesis, and AChE inhibitory activity of new benzothiazole\u2013piperazines","volume":"26","author":"\u00d6zkay","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117331_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.123669","article-title":"Exploring the impact of novel thiazole-pyrazole fused benzo-coumarin derivatives on human serum albumin: synthesis, photophysical properties,anti-cholinergic activity, and interaction studies","volume":"308","author":"Bhatta","year":"2024","journal-title":"Spectrochim. Acta: Mol. and Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2025.117331_bib109","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00044-022-02953-4","article-title":"Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer's disease","volume":"31","author":"Kumar","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117331_bib110","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1016\/j.bmc.2013.05.028","article-title":"Design, synthesis and neuroprotective evaluation of novel tacrine\u2013benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease","volume":"21","author":"Keri","year":"2013","journal-title":"Biooorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib111","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/molecules24030587","article-title":"New multitarget hybrids bearing tacrine and phenylbenzothiazole motifs as potential drug candidates for Alzheimer's disease","volume":"24","author":"Rajeshwari","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117331_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104596","article-title":"Tacrine \u2013 benzothiazoles: Novel class of potential multitarget anti-Alzheime\u0155 s drugs dealing with cholinergic, amyloid and mitochondrial systems","volume":"107","author":"Nepovimova","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ardp.201100124","article-title":"Synthesis and anticholinesterase activity and cytotoxicity of novel amide derivatives","volume":"345","author":"Altintop","year":"2012","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2025.117331_bib114","doi-asserted-by":"crossref","first-page":"23626","DOI":"10.1039\/D2RA03803J","article-title":"Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease","volume":"12","author":"Karaca","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117331_bib115","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.bmc.2013.01.052","article-title":"Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors","volume":"21","author":"Imramovsky","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101503","article-title":"A promising acetylcholinesterase and butyrylcholinesterase inhibitors: in vitro enzymatic and in silico molecular docking studies of benzothiazole-based oxadiazole containing imidazopyridine hybrid derivatives","volume":"7","author":"Hussain","year":"2024","journal-title":"Results in Chem"},{"key":"10.1016\/j.ejmech.2025.117331_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139200","article-title":"Hybrid benzothiazole derived fused triazole\/thiazole derivatives as versatile anti-Alzheimer agents: synthesis, characterization, biological evaluation and molecular docking studies","volume":"1318","author":"Khan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117331_bib118","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.ejmech.2005.05.010","article-title":"Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2,1-b]thiazole derivatives","volume":"40","author":"Andreani","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib119","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejmech.2007.04.018","article-title":"Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"43","author":"Andreani","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib120","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1021\/acschemneuro.4c00241","article-title":"Design of promising thiazoloindazole-based acetylcholinesterase inhibitors guided by molecular docking and experimental Insights","volume":"15","author":"Laghchioua","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117331_bib121","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/molecules24122306","article-title":"Synthesis, crystal structure, and biological evaluation of fused thiazolo[3,2-a]Pyrimidines as new acetylcholinesterase inhibitors","volume":"24","author":"Mahgoub","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117331_bib122","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bmc.2013.11.020","article-title":"Cholinesterase inhibitory activity versus aromatic core multiplicity: a facile green synthesis and molecular docking study of novel piperidone embedded thiazolopyrimidines","volume":"22","author":"Basiri","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117331_bib123","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/jhet.4863","article-title":"Design, synthesis, biological evaluation of a new tricyclicthiazolopy-rimidinone derivatives as acetylcholinesterase inhibitors","volume":"61","author":"Zeng","year":"2024","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117331_bib124","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1021\/acsomega.1c06344","article-title":"Design, synthesis, and bioevaluation of indole core containing 2-arylidine derivatives of thiazolopyrimidine as multitarget inhibitors of cholinesterases and monoamine oxidase A\/B for the treatment of alzheimer disease","volume":"7","author":"Nadeem","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.117331_bib125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2014.05.020","article-title":"Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors","volume":"81","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:05:17Z","timestamp":1759298717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":124,"alternative-id":["S0223523425000960"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117331","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117331"}}